作者: Srujan Kumar Dondapati , Marlitt Stech , Anne Zemella , Stefan Kubick
DOI: 10.1007/S40259-020-00417-Y
关键词:
摘要: Proteins are the main source of drug targets and some them possess therapeutic potential themselves. Among them, membrane proteins constitute approximately 50% major targets. In discovery pipeline, rapid methods for producing different classes in a simple manner with high quality important structural functional analysis. Cell-free systems emerging as an attractive alternative production due to their flexible nature without any cell constraints. bioproduction context, open based on lysates derived from sources, batch-to-batch consistency, have acted catalyst cell-free synthesis target proteins. Most importantly, can be processed downstream applications like purification analysis necessity transfection, selection, expansion clones. last 5 years, there has been increased availability new multiple organisms, use diverse range Despite this progress, challenges still exist terms scalability, cost effectiveness, protein folding, functionality. review, we present overview sources application wide spectrum Further, article discusses recent progress Chinese hamster ovary Sf21 containing endogenous translocationally active microsomes We particularly highlight usage internal ribosomal entry site sequences more efficient production, also significance site-specific incorporation non-canonical amino acids labeling creation antibody conjugates using systems. discuss strategies overcome involved commercializing platforms laboratory level future development.